Navigation Links
Hospira's Biosimilar Epoetin Retacrit(TM) Receives Positive Opinion Recommending EU Approval
Date:10/18/2007

f BIOCEUTICALS and Hospira.

Biopharmaceuticals, or biologics, are large-protein molecules derived from genetically modified cell lines. (In contrast, "traditional" pharmaceuticals are made from small-molecule, chemical substances.) A growing number of proprietary biopharmaceuticals' patents are expiring; and similar biologics are opening a large, emerging market. Hospira has significantly invested in expanding its comprehensive competencies to develop, manufacture and market similar biologics.

The European Commission approves similar biologics that demonstrate quality, efficacy and safety that are similar to currently available biopharmaceuticals in the approved indications. It has already approved other similar biologics. A comparable legal and regulatory approval pathway does not yet exist in the United States.

About STADA

STADA Arzneimittel AG, headquartered in Bad Vilbel, Germany, is an international pharmaceutical company with a focus on generic and non-patented branded pharmaceutical products. STADA is one of the leading generic companies in Germany and in the European Union. It is listed on the Frankfurt Stock Exchange. STADA's news releases and other information can be found at http://www.stada.com.

About BIOCEUTICALS

Initiated by STADA and located in Bad Vilbel, Germany, BIOCEUTICALS Arzneimittel AG is focused on the development of biosimilar products. BIOCEUTICALS is predominantly financed via venture capital and is not quoted on a stock exchange.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM) by developing, manufacturing and marketing products that help improve the productivity, safety and efficacy of patient care. In February 2007, Hospira acquired Mayne Pharma Limited to become the world leader in specialty generic injectable pharmaceuticals. With 70 years of service to the
'/>"/>

SOURCE Hospira, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Medical College receives $377K to study brain disease
2. Lucigen receives $750K grant to boost biofuel yields
3. Medical College receives $1.4M cancer grant
4. Wisconsin biotech firm receives $107K NIH grant
5. InvivoSciences receives NIH grant for heart technology
6. Medical College receives $11 million grant to study high blood pressure
7. Madison business receives $115,000 of new state biofuels funding
8. Superior receives funds for technical training
9. UWM receives state funding for plastics research
10. GEs Centricity EHR receives federal certification
11. WHIE receives state eHealth Initiative contract
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... (July 21, 2014) The yield so far is ... developed a low-energy, solution-based mineral substitution process to make ... use in electronics and alternative energy devices. , A ... of the July 21 issue of the journal ... research in the inorganic and nuclear chemistry fields. The ...
(Date:7/20/2014)... fuel gets recycled, the process releases radioactive krypton and ... with the related gas radon. A new porous material ... July 20 in Nature Materials shows how: ... not out. , The CC3 material could be ... nuclear fuel or air in buildings and also in ...
(Date:7/18/2014)... , July 18, 2014  Neogen Corporation (Nasdaq: ... Snyder , Neogen,s chief operating officer and president, has ... will work as a consultant going forward on special ... Snyder has been in this position since September 2013. ... by James Herbert , who has been Neogen,s ...
(Date:7/18/2014)... , July 18, 2014  Neurotrope, Inc. (OTCQB: ... Board of Directors appointed Co-Chairmen Charles S. Ramat ... Officers on an interim basis, effective immediately. Messrs. Ramat ... is no longer Chief Executive Officer of Neurotrope Bioscience, ... Company and whose employment agreement with Neurotrope Bioscience Inc. ...
Breaking Biology Technology:Oregon chemists eye improved thin films with metal substitution 2A noble gas cage 2A noble gas cage 3Neurotrope Board of Directors Appoints Chairmen Ramat and Freiman as Interim Co-CEOs 2Neurotrope Board of Directors Appoints Chairmen Ramat and Freiman as Interim Co-CEOs 3Neurotrope Board of Directors Appoints Chairmen Ramat and Freiman as Interim Co-CEOs 4
... AVIV, Israel, October 15 ,Simbionix USA Corporation is ... round of growth capital financing led by River ... Partners and other existing,shareholders, as well as Western ... The investment will enable Simbionix to,accelerate the already ...
... PURE Bioscience (Nasdaq:,PURE), creators of the patented ... the fiscal year ended July 31, 2008 of,$1,487,500, ... in the,prior fiscal year. The Company reported a ... per share, compared with a loss of,$(4,654,900), or ...
... Calif., Oct. 15 SuperGen, Inc.,(Nasdaq: SUPG ... and,development of novel cancer therapies, today announced the ... EORTC-NCI-AACR Symposium on "Molecular,Targets and Cancer Therapeutics" on ... will review clinical and non-clinical advances,in the following ...
Cached Biology Technology:Simbionix Raises Largest Amount in Company's History in Venture Capital to Accelerate Growth 2Simbionix Raises Largest Amount in Company's History in Venture Capital to Accelerate Growth 3PURE Bioscience Reports Fourth Quarter and Year End Results 2PURE Bioscience Reports Fourth Quarter and Year End Results 3PURE Bioscience Reports Fourth Quarter and Year End Results 4PURE Bioscience Reports Fourth Quarter and Year End Results 5PURE Bioscience Reports Fourth Quarter and Year End Results 6PURE Bioscience Reports Fourth Quarter and Year End Results 7SuperGen to Present Data at EORTC-NCI-AACR 2
(Date:7/21/2014)... areas across Riau province on Sunday, July 20, indicating ... decline in rainfall. The number of detected hotspots ... been reported one day prior, which had reached only ... regencies and municipalities, most of which were in northern ... creates could potentially spread via winds to Malaysia and ...
(Date:7/21/2014)... CHAMPAIGN, Ill. A new study in mice reveals ... muscle after resistance exercise. , By injecting MSCs ... eccentric exercise (similar to the lengthening contractions performed during ... damage), researchers were able to increase the rate of ... muscles in the exercising mice. , The findings, ...
(Date:7/21/2014)... yourself full of high-fat foods cause you to lose ... Florida State University neuroscientists says so, and it has ... could impact a whole range of human functions that ... obesity. , "This opens up a lot of possibilities ... Nicolas Thiebaud, who led the study examining how high-fat ...
Breaking Biology News(10 mins):Stem cells aid muscle repair and strengthening after resistance exercise 2New research links bad diet to loss of smell 2
... trillions of cells, all derived from a single cell, or zygote, ... single cell contains all the genetic information needed to develop into ... new cell as it divides into the many diverse types of ... If each cell is genetically identical, however, how does ...
... make sure their children drink milk and eat other calcium-rich foods ... make sure their kids eat salmon, almonds and other foods high ... in bone health, according to a study to be presented Sunday, ... Washington, DC. "Lots of nutrients are key for children ...
... and/or improve the quality of life for many cancer patients. ... inducing damage to DNA. The public has an opportunity ... used anticancer drugs and how laboratory research may lead to ... Yinsheng Wang , a professor of chemistry at ...
Cached Biology News:Divide and define: Clues to understanding how stem cells produce different kinds of cells 2Divide and define: Clues to understanding how stem cells produce different kinds of cells 3Magnesium may be as important to kids' bone health as calcium 2How do anticancer drugs work? 2How do anticancer drugs work? 3
Immunogen: Synthetic peptide (aa sequence is considered to be commercially sensitive) Storage: -20 C, Avoid Freeze/Thaw Cycles...
... Immunogen: Recombinant human IDO (Indoleamine-pyrrol ... the ~44 kDa human IDO ... control: IFN-Gamma-stimmulated Human peripheral blood ... reactivity with mouse and rat ...
...
Anti-ZFP-38/RU49 Family: Zinc Finger Peptide Sequence: SVKVEDKDFPSTCSKK...
Biology Products: